* Santalis announces first subject enrolled in phase 2 trial of east indian sandalwood oil (eiso) to treat mild to moderate plaque psoriasis Source text for Eikon: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback